Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 4 | 0 | 0 | 0 | 0 |
| Gross Profit | 4 | N/A | N/A | N/A | N/A |
| Operating Expenses | 4,552 | 3,220 | 4,820 | 2,107 | 2,092 |
| Operating Income | -4,548 | -3,209 | -4,820 | -2,107 | -2,092 |
| Other Income | -8 | 5 | 103 | -1 | 22 |
| Pre-tax Income | -4,556 | -3,204 | -4,717 | -2,108 | -2,070 |
| Net Income Continuous | -4,556 | -3,204 | -4,717 | -2,108 | -2,070 |
| Net Income | $-4,556 | $-3,204 | $-4,717 | $-2,108 | $-2,070 |
| EPS Basic Total Ops | -0.32 | -0.26 | -0.36 | -0.20 | -0.19 |
| EPS Basic Continuous Ops | -0.32 | -0.26 | -0.36 | -0.20 | -0.19 |
| EPS Diluted Total Ops | -0.32 | -0.26 | -0.36 | -0.20 | -0.19 |
| EPS Diluted Continuous Ops | -0.32 | -0.26 | -0.36 | -0.20 | -0.19 |
| EBITDA(a) | $-4,548 | $-3,220 | $-4,820 | $-2,107 | $-2,092 |